20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6S0655 | Corynoxeine | ERK | |
1. Corynoxeine is a potent ERK1/2 inhibitor of key PDGF-BB-induced VSMC proliferation and may be useful in the prevention and treatment of vascular diseases and restenosis after angioplasty. | |||
TN2346 | Mogrol | ERK , AMPK , STAT | |
Mogrol, a biometabolite of mogrosides, functions by inhibiting the ERK1/2 and STAT3 pathways, diminishing CREB activation, and activating AMPK signaling. | |||
T5358 | Longdaysin | ERK , Casein Kinase , CDK | |
Longdaysin is an inhibitor of CK1α and CK1δ (IC50s: 5.6/8.8 µM). It also can inhibit ERK2 (IC50: 52 µM). | |||
T10479 | BAY885 | ERK | |
BAY885 is a new ERK5 inhibitor. | |||
T14360 | AX-15836 | ERK | |
AX-15836 is an inhibitor of ERK5 (IC50 : 8 nM). | |||
TQ0005 | KO-947 | ERK | |
KO-947 is a potent and specific inhibitor of ERK1/2 kinases. | |||
T14894 | CC-90003 | ERK | |
CC-90003 is a selective inhibitor of ERK 1/2. It has antitumor activity. | |||
T6066 | SCH772984 | ERK , MEK | |
SCH 772984 is a potent inhibitor of ERK1/ERK2 (IC50: 4/1 nM) and has only weak inhibitory for other 300 tested kinases. | |||
T3856 | Tenuifoliside A | ERK , Others | |
Tenuifoliside A has anti-apoptotic , neuroprotective activity. And tenuifoliside A has anti-inflammatory effect, which is mediated by the inhibition of the NF-κB and MAPK pathways. | |||
T5535 | ERK5-IN-2 | ERK | |
ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively. | |||
T5184 | ERK5-IN-1 | ERK | |
ERK5-IN-1 is a potent ERK5 inhibitor (IC50: 87 nM). It also inhibits LRRK2[G2019S] (IC50: 26 nM). | |||
T3857 | Magnolin | (+)-Magnolin | ERK |
Magnolin reduces the renal oxidative stress, suppresses caspase-3 activity, and increases Bcl-2 expression in vivo and in vitro. Magnolin has anti-inflammatory and antioxidative effects. | |||
T6818 | DEL-22379 | DEL22379 | Apoptosis , ERK |
DEL-22379 is a water-soluble ERK dimerization inhibitor with IC50 of ~0.5 μM. | |||
T1956 | FR 180204 | FR180204 | Apoptosis , ERK |
FR 180204 is a potent and selective ATP-competitive inhibitor of ERK1 and ERK2. | |||
T4091 | Temuterkib | LY3214996 | ERK |
Temuterkib (LY3214996) is a potent and selective, orally available inhibitor of the extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity. | |||
T10429 | Tizaterkib | AZD-0364 | ERK |
Tizaterkib (AZD-0364) is a potent and selective ERK2 inhibitor. | |||
T6511 | Ravoxertinib | GDC-0994 | ERK |
Ravoxertinib (GDC-0994) is an effective and orally available ERK1/2 inhibitor (IC50: 1.1/0.3 nM). | |||
T3844 | Deltonin | ERK , Others , Akt , Endogenous Metabolite | |
Deltonin has an inhibition of ERK1/2 and AKT activation. Deltonin shows cytotoxicity against human HepG2 cells (IC50: 7.66 μM), mouse C26 cells (IC50: 1.22 μM), and human MDA-MB-231 cells (IC50: 1.58 μM). | |||
T36674 | DMU-212 | Apoptosis , ERK | |
DMU-212 is a methylated derivative of Resveratrol , with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities. DMU-212 induces mitotic arrest via induction of apoptosis and activation of ERK1/2... | |||
T11224 | Rineterkib | ERK-IN-1 | ERK , Raf |
Rineterkib (ERK-IN-1) is an inhibitor of RAF and ERK1/2 activating mutations in the MAPK pathway. |